What did @cbronsonmd actually say?
The claim here is straightforward but contains a significant error. @cbronsonmd states that hCG "at the end of cycle or during PCT" is insufficient if your goal is fertility preservation, and that you need to take it "while you're doing your cycle." That second part is correct. The first part, framing end-of-cycle or PCT as an alternative option worth mentioning, muddies the water in a way that could mislead viewers who are actively trying to protect their reproductive health.
The clip is short, the language is casual, and it sounds like it could be a snippet pulled from a longer, more nuanced video. That matters, because without that context, viewers who catch only this version may walk away with a muddled understanding of why timing is so critical.
Does the science back this up?
Yes, substantially, but with important nuance. The research on hCG co-administration during anabolic steroid use is fairly consistent. Exogenous testosterone suppresses LH (luteinizing hormone), which normally signals the Leydig cells in the testes to produce testosterone and support spermatogenesis. hCG mimics LH activity, keeping that intratesticular testosterone production alive while exogenous androgens suppress the HPG axis.
Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) demonstrated that low-dose hCG co-administration during testosterone suppression maintained intratesticular testosterone concentrations. Schlegel (2012, Fertility and Sterility) confirmed that intratesticular testosterone is essential for normal sperm production. The implication is direct: if you wait until PCT to introduce hCG, the Leydig cells have already been dormant, potentially for weeks or months. Recovery is not instantaneous.
Researchers like Ramasamy et al. (2015, Journal of Urology) have documented that testicular atrophy and impaired spermatogenesis from prolonged androgen use can take months to reverse, and in some cases, recovery is incomplete.
What did they get wrong (or right)?
The right part: co-administration during a cycle is the evidence-supported strategy. Give credit where it is due. The recommendation to use hCG concurrently is backed by the literature and is increasingly standard in clinical discussions around fertility-conscious testosterone use.
The problematic part: presenting hCG "at the end of cycle or during PCT" as a recognizable option, even one he is arguing against, frames it as a legitimate alternative when it is actually a common and consequential mistake. The physiology is unforgiving here. Once the HPG axis is suppressed and testicular volume has dropped, hCG is doing remediation work, not prevention. That is a harder lift.
There is also no mention of semen analysis, which is the only way to know whether fertility is actually being preserved. Self-reported testicular size and libido are not reliable proxies for sperm count or motility. Patients who care about this outcome need objective data.
What should you actually know?
If fertility preservation is a real priority for you, this is not a detail you can approximate. Intratesticular testosterone, not serum testosterone, drives spermatogenesis. Those are two different compartments with different regulatory mechanisms. Exogenous testosterone alone raises serum levels but can suppress intratesticular levels by up to 94%, according to Coviello et al. (2005).
Starting hCG concurrently with an anabolic cycle is the approach with the most evidence behind it. Starting it after suppression has already occurred is reactive, and the recovery timeline is unpredictable. Some men recover spermatogenesis fully within six months post-cycle. Others take over a year. A subset show persistent impairment, as documented in Fronczak et al. (2012, Fertility and Sterility).
If you are using testosterone or anabolic compounds and fertility matters to you, a baseline semen analysis before you start, and follow-up analysis during and after, is the only way to know what is actually happening. A urologist or reproductive endocrinologist, not just a general TRT prescriber, should be in that conversation.
Bottom line on this clip
The core message is right. The framing has enough ambiguity to cause harm if someone walks away thinking PCT-timing is a close second option. It is not. The biology favors prevention over recovery, consistently and clearly.